BSG and lung cancer: A study on tumor-stromal interactions noted that when MVs were co-released with extracellular matrix metalloproteinase inducer (EMMPRIN/CD147), they prompted lung cancer cells to obtain increased mobility and invasion ability by promoting metalloproteinase to capture and digest extracellular matrix (ECM)[68].